联系客服QQ:86259698

000513 深市 丽珠集团


首页 公告 丽珠集团:2025年半年度财务报告

丽珠集团:2025年半年度财务报告

公告日期:2025-08-21

丽珠医药集团股份有限公司
 2025 年半年度财务报告

      (未经审计)

      2025 年 8 月


                    财务报告

一、审计报告
半年度报告是否经过审计
□ 是 √ 否
本公司半年度财务报告未经审计。

二、财务报表

                  合并及公司资产负债表

编制单位:丽珠医药集团股份有限公司                              金额单位:人民币元

                                                  期末数                                年初数

        项  目            附注

                                          合并              公司              合并              公司

流动资产:

 货币资金                  五、1    10,352,467,614.29    5,449,568,487.88    10,827,146,984.92    6,635,542,800.19
 交易性金融资产            五、2      258,321,589.51      113,389,509.97      89,363,055.07      11,404,575.20
 应收票据                  五、3      1,143,554,768.40      596,955,068.86    1,313,604,720.17      673,226,891.51
 应收账款                  五、4      2,301,463,456.31    1,031,158,102.62    1,935,502,036.72      972,481,999.45
 应收款项融资                                      -                  -                  -                  -
 预付款项                  五、5      139,386,597.12      35,007,344.51      149,477,979.10      33,948,499.09
 其他应收款                五、6        43,537,896.67      181,090,372.06      34,558,694.17      343,051,410.41
  其中:应收利息                                    -                  -                  -                  -
        应收股利                          146,732.76                  -                  -                  -
 存货                      五、7      1,714,611,456.84      278,521,492.92    1,997,642,296.29      430,530,510.77
 合同资产                                          -                  -                  -                  -
 持有待售资产                                      -                  -                  -                  -
 一年内到期的非流动资产    五、8      214,121,617.17      214,121,617.17                  -                  -
 其他流动资产              五、9        70,712,661.88          443,555.11      72,684,877.86          443,555.11
      流动资产合计                  16,238,177,658.19    7,900,255,551.10    16,419,980,644.30    9,100,630,241.73
非流动资产:

 债权投资                                          -                  -                  -                  -
 其他债权投资                                      -                  -                  -                  -
 长期应收款                                        -                  -                  -                  -
 长期股权投资              五、10    1,075,561,617.48    4,791,296,671.52    1,056,220,316.06    4,639,108,916.39
 其他权益工具投资          五、11      558,309,364.71      300,947,483.90      561,645,609.43      301,855,344.29
 其他非流动金融资产                                -                  -                  -                  -
 投资性房地产              五、12        9,505,412.42                  -        9,925,854.14                  -
 固定资产                  五、13    4,122,580,653.78      68,969,572.06    4,254,805,388.16      73,100,631.48
 在建工程                  五、14      287,181,711.89          597,551.25      257,366,336.12          270,028.31
 生产性生物资产                                    -                  -                  -                  -
 油气资产                                          -                  -                  -                  -
 使用权资产                五、15        27,488,747.28        3,548,002.45      25,083,211.98        1,984,702.44
 无形资产                  五、16      491,674,761.81      35,792,384.58      403,681,866.63      28,202,791.90
 开发支出                  五、17      292,037,483.65      168,477,248.49      220,497,980.76      128,218,680.33
 商誉                      五、18      124,911,302.94                  -      124,911,302.94                  -
 长期待摊费用              五、19      162,862,193.48        6,393,200.65      175,748,366.88        7,915,196.40
 递延所得税资产            五、20      383,939,697.45      210,736,019.56      356,345,428.36      165,234,242.75
 其他非流动资产            五、21      398,639,433.59      130,785,443.69      589,613,391.42      332,709,154.32
      非流动资产合计                  7,934,692,380.48    5,717,543,578.15    8,035,845,052.88    5,678,599,688.61
        资产总计                    24,172,870,038.67    13,617,799,129.25    24,455,825,697.18    14,779,229,930.34


                合并及公司资产负债表(续)

编制单位:丽珠医药集团股份有限公司                              金额单位:人民币元

                                                        期末数                          年初数

              项  目              附注

                                                  合并            公司            合并            公司

流动负债:

 短期借款                          五、23  2,130,000,000.00                -  2,455,000,000.00                -
 交易性金融负债                                    8,581.94                -      8,096,946.08                -
 应付票据                          五、24    833,253,202.89  2,080,491,534.82    965,581,088.61  2,312,599,858.49
 应付账款                          五、25    556,966,971.46    556,446,109.49    618,397,523.74    315,012,554.57
 预收款项                                                -                -                -